Biopharma Food Healthcare Provider Pharmaceutical manufacturing 
Clarivate
MARCH 14, 2024
Over the past few years nitrosamines and nitrosamine impurities have been increasingly gaining the reputation of being high-risk containments in the food industry. The food sector has already initiated the publication of preliminary regulations aimed at restricting PFAS in packaging. [3].
European Pharmaceutical Review
DECEMBER 21, 2022
The healthcare industry is successful in innovating new treatment paradigms ranging from small molecular to biological therapeutics to personalised medicines. Defossilization of pharmaceutical manufacturing. Biopharma successful in achieving climate-related goals, report finds … . 33, February 2022, 100586.
Expert insights. Personalized for you.
52 
Let's personalize your content